Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection
The FDA Advisory No. 531-20, issued on April 3, 2020, warns the public against unapproved and misleading advertisements for food products and supplements that falsely claim to boost immunity or reduce the risk of COVID-19 infection. The advisory highlights specific products that have been found to promote these deceptive claims and emphasizes that no food products or supplements can prevent or cure COVID-19. The FDA urges consumers to be vigilant and to rely on accurate public health information from the Department of Health and the World Health Organization. Market Authorization Holders of the misleading products are warned to cease such promotions, with potential regulatory actions outlined for non-compliance.
Quick Answers
- What is Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection about?
- The FDA Advisory No. 531-20, issued on April 3, 2020, warns the public against unapproved and misleading advertisements for food products and supplements that falsely claim to boost immunity or reduce the risk of COVID-19 infection. The advisory highlights specific products that have been found to promote these deceptive claims and emphasizes that no food products or supplements can prevent or cure COVID-19. The FDA urges consumers to be vigilant and to rely on accurate public health information from the Department of Health and the World Health Organization. Market Authorization Holders of the misleading products are warned to cease such promotions, with potential regulatory actions outlined for non-compliance.
- What type of law is FDA Advisory No. 531-20?
- Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection (FDA Advisory No. 531-20) is a Philippine Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances enacted by the Congress of the Philippines.
- When was Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection enacted?
- Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection (FDA Advisory No. 531-20) was enacted on Apr 3, 2020.
- What is the citation for Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection?
- Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection, FDA Advisory No. 531-20, Apr 3, 2020 (Philippines)
Law Information
- Reference Number
- FDA Advisory No. 531-20
- Date Enacted
- Subcategory
- Food and Drugs Administration of the Philippines
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
April 3, 2020
FDA ADVISORY NO. 531-20
| TO | : | The General Public |
| SUBJECT | : | Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Corona virus Disease (COVID)-19 Infection |
The Food and Drug Administration (FDA) warns the public against unapproved and misleading advertisements and promotion of various food products and food supplements monitored online:
Figure 1. Misleading Advertisement of UNREGISTERED Honey-C Vitamin C Supplement
Figure 2. Misleading Advertisement of GLUTA-WHITE and GLUTA-WHITE 500 Food Supplement Capsules
Figure 3. Misleading Advertisement of KINGS HERBAL Food Supplement Liquid
Figure 4. Misleading Advertisement of ONE OPTI JUICE Herbal Proprietary Blend Powdered Juice
Figure 5. Misleading Advertisement of SANTE BARLEY Pure Barley Food Supplement Powder
The public is hereby advised to be vigilant against such deceptive marketing of food products and food supplements. Food products and food supplements shall not, in any way, prevent, cure and especially reduce the risk of COVID-19 and any other diseases, and should not bear any misleading, deceptive, and false claims on their labels and/or any promotional materials that will provide erroneous impression on the product's character or identity.
Further, the FDA would like to emphasize that of this time, there are no specific vaccines or treatments for COVID-19. Everyone is encouraged to follow accurate public health advice and guidance from the Department of Health and the World Health Organization on basic protective measures against COVID-19. CAIHTE
All Market Authorization Holders of these food products and food supplements are sternly warned and hereby directed to stop such misleading advertisements and promotions. Appropriate regulatory tools and sanctions shall be executed to such companies that are continuously conducting such and other similar activities upon issuance of this Advisory.
Dissemination of this advisory to all concerned is hereby requested.
(SGD.) ROLANDO ENRIQUE D. DOMINGO, DPBODirector General
Cite This Law
Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection, FDA Advisory No. 531-20, Apr 3, 2020 (Philippines)
Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 Infection, FDA Advisory No. 531-20 (Phil. 2020)
Related Laws
- Public Health Warning against the Unapproved and Misleading Health Claims of Medical Devices That Decrease the Risk for Corona Virus Disease (COVID-19) InfectionFDA Advisory No. 782-20 • May 7, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Public Health Warning against the Purchase and Use of Disinfectants/Biocides Products with Misleading Health Claims That Decrease the Risk for Corona Virus Disease (COVID-19) InfectionFDA Advisory No. 852-20 • May 15, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Guidelines for the Registration of Drug Products under Emergency Use (DEU) for the Coronavirus Disease 2019 (COVID-19)FDA Circular No. 012-20 • Apr 2, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Guide to Disinfect the Workplace Premises using Products known to be Effective against the Human CoronavirusPEZA Memorandum Circular No. 018-20 • Mar 27, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Guidelines for the Inclusion of the COVID-19 in the List of Notifiable Diseases for Mandatory Reporting to the Department of HealthDOH Administrative Order No. 2020-0012 • Mar 17, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Guidelines on the Risk-Based Public Health Standards for COVID-19 MitigationDOH Administrative Order No. 2020-0015 • Apr 27, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Browse More Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Explore other laws in the Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances category.
View All Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law